A monumental global study has significantly advanced our understanding of prostate cancer genetics, identifying 451 genetic variants linked to the disease’s risk.
Led by the USC Center for Genetic Epidemiology and the Keck School of Medicine, alongside The Institute of Cancer Research in London, this research stands out as the largest and most diverse genetic investigation into prostate cancer to date.
It revises the current knowledge of who is genetically at risk by including a much larger representation of men from various racial and ethnic backgrounds.
By analyzing genomic data from nearly 950,000 men, the researchers refined a genetic risk measurement system, making it more precise in predicting prostate cancer occurrences.
This system is particularly effective for men of African descent, differentiating between the risks for more aggressive and less serious forms of prostate cancer.
Genetic Variants and Aggressive Disease
This study, published in Nature Genetics, is a significant leap from previous research, which identified 269 genetic variants.
The new findings show that men with higher genetic risk scores, especially those of African ancestry, are more likely to develop severe forms of the disease. This connection underscores the importance of diverse genetic research in understanding and combating prostate cancer.
Christopher Haiman, ScD, emphasizes the crucial need for diversity in genetic studies. “To develop risk prediction tools that are effective across all populations, we need to study more than just white men,” he says.
The study’s inclusivity marks a step toward precision medicine that considers genetic differences across populations.
Significant Increase in Diverse Genetic Data
The study’s comprehensive approach included an 87% increase in prostate cancer cases among men of African ancestry, with substantial increases from other racial and ethnic groups as well.
This vast dataset led to the discovery of 187 new genetic variants associated with prostate cancer risk.
The findings promise to inform clinical decisions, potentially leading to genetic testing that could pinpoint individuals at risk for aggressive prostate cancer. Such advancements could enable more targeted and frequent screenings, improving early detection rates.
The enhanced risk score system developed from this research can now better predict the likelihood of developing prostate cancer and its potential severity. This differentiation is crucial in preventing unnecessary treatments that can negatively impact patients’ quality of life.
The study’s success was a testament to international collaboration, with over 300 researchers from more than 100 institutions across 26 nations contributing. This collective effort showcases the potential of worldwide cooperation in scientific research.
While the study provides significant insights, further clinical trials are necessary to test the effectiveness of the risk score in real-world screening and treatment scenarios.
The research paves the way for ongoing improvements in understanding and managing prostate cancer risk globally.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and vitamin D supplements could strongly reduce cancer death.
For more information about health, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing higher intake of dairy foods linked to higher prostate cancer risk.
The research findings can be found in Nature Genetics.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.